Drug companies are saturating the test markets with potential treatments for the novel coronavirus.<br />A top US regulator has cautioned that conducting so many studies could be a challenge.<br />Dr. Janet Woodcock, of the FDA, said the agency has received over 950 proposals for coronavirus treatments.<br />"Although we may not run out of patients, unfortunately, we may run out of research personnel"<br />Dr. Janet Woodcock<br />Woodcock said the current medication trial system has to change to meet the demand.<br />It's a position she has long advocated for, previously calling the US clinical trial system "broken."<br />Woodcock said; "This crisis underlies and points out the need to have a better clinical trial infrastructure in place".
